Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Gastric Ultrasound Clinical Trial

Official title:
Evaluation of Gastric Insufflation Measured by Ultrasound of the Antral Surface During Optiflow Preoxygenation

Status Recruiting

Clinical Trial Summary

Check in gastric ultrasound for lack of stomach insufflation during preoxygenation with high-flow nasal cannulas

n/a

NCT number	NCT04206111
Study type	Observational
Source	University of Liege
Contact	Benjamin Javillier, MD
Phone	003243667180
Email	benjamin.javillier@chuliege.be
Status	Recruiting
Phase
Start date	June 1, 2020
Completion date	October 1, 2020

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04277013` - Ultrasound Assessment of Gastric Content in Fasted Pregnant Women
Completed	`NCT03205774` - Positioning and Ultrasound Examination of the Gastric Antrum	N/A
Completed	`NCT04738006` - Establishing Gastric Sonography in a Swiss Teaching Hospital
Recruiting	`NCT04760106` - Learning Curves of Gastric Ultrasound for Novel
Recruiting	`NCT06003985` - Gastric Ultrasound Assessment for Patients Taking GLP1 Agonists